Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
- 1.1k Downloads
Procalcitonin (PCT)-guided antibiotic stewardship is a successful strategy to decrease antibiotic use. We assessed if clinical judgement affected compliance with a PCT-algorithm for antibiotic prescribing in a multicenter surveillance of patients with lower respiratory tract infections (LRTI).
Initiation and duration of antibiotic therapy, adherence to a PCT algorithm and outcome were monitored in consecutive adults with LRTI who were enrolled in a prospective observational quality control. We correlated initial clinical judgment of the treating physician with algorithm compliance and assessed the influence of PCT on the final decision to initiate antibiotic therapy.
PCT levels correlated with physicians’ estimates of the likelihood of bacterial infection (p for trend <0.02). PCT influenced the post-test probability of antibiotic initiation with a greater effect in patients with non-pneumonia LRTI (e.g., for bronchitis: −23 % if PCT ≤ 0.25 μg/L and +31 % if PCT > 0.25 μg/L), in European centers (e.g., in France −22 % if PCT ≤ 0.25 μg/L and +13 % if PCT > 0.25 μg/L) and in centers, which had previous experience with the PCT-algorithm (−16 % if PCT ≤ 0.25 μg/L and +19 % if PCT > 0.25 μg/L). Algorithm non-compliance, i.e. antibiotic prescribing despite low PCT-levels, was independently predicted by the likelihood of a bacterial infection as judged by the treating physician. Compliance was significantly associated with identification of a bacterial etiology (p = 0.01).
Compliance with PCT-guided antibiotic stewardship was affected by geographically and culturally-influenced subjective clinical judgment. Initiation of antibiotic therapy was altered by PCT levels. Differential compliance with antibiotic stewardship efforts contributes to geographical differences in antibiotic prescribing habits and potentially influences antibiotic resistance rates.
KeywordsAntibiotic Therapy Community Acquire Pneumonia Lower Respiratory Tract Infection Antibiotic Prescribe Lower Respiratory Tract Infection
We are grateful to all of the patients, physicians and nursing staff from the centers who participated in this survey.
Conflict of Interest
Drs Albrich, Schuetz, and Mueller have received support from BRAHMS AG to attend meetings and fulfill speaking engagements. Dr Amin has received speaking honoraria from bioMérieux. Drs Albrich and Mueller have received support from bioMérieux to attend meetings. Dr Mueller has served as a consultant to and received research support from BRAHMS AG and bioMérieux.
- 1.Grill MF, Maganti RK (2011) Neurotoxic effects associated with antibiotic use: management considerations. BJCP 72(3):381–93Google Scholar
- 5.Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008) Antimicrobial drug use and resistance in Europe. EID 14(11):1722–30Google Scholar
- 6.Albrich WC, Monnet DL, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID 10(3):514–517Google Scholar
- 15.Finch RG, Metlay JP, Davey PG, Baker LJ, International Forum on Antibiotic Resistance (2002) Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4(1):44–53Google Scholar
- 17.Harbarth S, Albrich W, Brun-Buisson C (2002) Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. EID 8(12):1460–1467Google Scholar
- 18.Filippini M, Masiero G, Moschetti K (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Healthpol 78(1):77–92Google Scholar
- 19.Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409)Google Scholar
- 20.Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. AJRCCM 174(1):84–93Google Scholar
- 25.Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuehn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life” - an international, multicenter poststudy survey (ProREAL). Arch Int Med 172(9):715–722CrossRefGoogle Scholar
- 26.Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C et al (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 7:102PubMedCrossRefGoogle Scholar
- 36.Grol R, Grimshaw J (1999) Evidence-based implementation of evidence-based medicine. Joint Comm J Qual Im 25(10):503–513Google Scholar
- 38.Kitto S, Petrovic A, Gruen RL, Smith JA (2011) Evidence-based medicine training and implementation in surgery: the role of surgical cultures. JECP 17(4):819Google Scholar